Royal DSM has today announced that it has filed a patent infringement lawsuit regarding its DHA (docosahexaenoic acid) algal oil innovations in the United Kingdom (UK). The lawsuit, which was filed 10 January 2023, follows alleged unlawful use of the company’s patented technologies by Mara Renewables Corporation (Mara) and Algal Omega-3 Ltd (AO3) to produce DHA oil.
As well as claiming financial compensation for past and ongoing infringement, DSM has asked the court to order that both Mara and AO3 cease the production and sale of DHA oil produced using its patented technologies.
Said Gareth Barker, Senior Vice President, Global Marketing and Business Development, DSM: “DSM first developed algal-based nutritional lipids more than 35 years ago – and was the first ever company to bring these game-changing products to market. Since then, we’ve worked hard to uphold our position in the space with a strong commitment to continuous innovation and sustainability through ongoing investments. Concurrently, we’ve built a comprehensive patent portfolio to protect both our cutting-edge technologies and the business we’ve created.”
DSM holds a broad portfolio of patents in various countries including the US, Canada, Europe and China, many of which are valid beyond 2031. DSM will continue to monitor third party activities in various markets for potential infringement. For more visit dsm.com
